Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment

被引：0

作者：

Hao Yuan Kueh

Mary A Yui

Kenneth K H Ng

Shirley S Pease

Jingli A Zhang

Sagar S Damle

George Freedman

Sharmayne Siu

Irwin D Bernstein

Michael B Elowitz

Ellen V Rothenberg

机构：

[1] California Institute of Technology,Division of Biology and Biological Engineering

[2] Fred Hutchinson Cancer Research Center,Clinical Research Division

[3] Howard Hughes Medical Institute,undefined

[4] California Institute of Technology,undefined

[5] Present addresses: Department of Bioengineering,undefined

[6] University of Washington,undefined

[7] Seattle,undefined

[8] Washington,undefined

[9] USA (H.Y.K.),undefined

[10] Genentech,undefined

[11] South San Francisco,undefined

[12] California,undefined

[13] USA (J.A.Z.),undefined

[14] Department of Bioinformatics,undefined

[15] Antisense Drug Discovery,undefined

[16] Isis Pharmaceuticals,undefined

[17] Carlsbad,undefined

[18] California,undefined

[19] USA (S.S.D.),undefined

[20] and Department of Pediatrics,undefined

[21] University of California,undefined

[22] San Francisco School of Medicine,undefined

[23] San Francisco,undefined

[24] California,undefined

[25] USA (G.F.).,undefined

来源：

Nature Immunology | 2016年 / 17卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Kueh, Rothenberg and colleagues describe distinct, asynchronous and stage-specific mechanisms of T cell commitment mediated by the transcription factors Notch, TCF-1, GATA-3 and Runx1.

引用

页码：956 / 965

页数：9

共 50 条

[31] The role of BCL11B in regulating the proliferation of human naive T cells
Chen, Si
Huang, Xin
Chen, Shaohua
Yang, Lijian
Shen, Qi
Zheng, Haitao
Li, Bo
Grabarczyk, Piotr
Przybylski, Grzegorz K.
Schmidt, Christian A.
Li, Yangqiu
HUMAN IMMUNOLOGY, 2012, 73 (05) : 456 - 464
[32] Human BCL11B is expressed in normal T cells and differentially expressed in T-cell malignancies.
Pulford, K
Lyne, L
Roncador, G
Kominami, R
Banham, AH
BLOOD, 2005, 106 (11) : 177B - 177B
[33] Bcl11b is essential for group 2 innate lymphoid cell development
Walker, Jennifer A.
Oliphant, Christopher J.
Englezakis, Alexandros
Yu, Yong
Clare, Simon
Rodewald, Hans-Reimer
Belz, Gabrielle
Liu, Pentao
Fallon, Padraic G.
McKenzie, Andrew N. J.
JOURNAL OF EXPERIMENTAL MEDICINE, 2015, 212 (06): : 875 - 882
[34] Discovery of a bis-phosphokinetic motif in a regulatory region of the transcription factor, BCL11B
Filtz, Theresa Marie
Vogel, Walter K.
Gafken, Philip R.
Leid, Mark
FASEB JOURNAL, 2013, 27
[35] BCL11B Upregulates the Expression of RelA in T Cells Stimulated with Staphylococcal Enterotoxin A
Yan, Y.
Wang, S.
Lin, C.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 174 (02) : 259 - 264
[36] BCL11B Upregulates the Expression of RelA in T Cells Stimulated with Staphylococcal Enterotoxin A
Y. Yan
S. Wang
C. Lin
Bulletin of Experimental Biology and Medicine, 2022, 174 : 259 - 264
[37] Short-form of BCL11B contributes to tumorigenesis of adult T-cell leukemia/lymphoma
Permatasari, Happy
Nakahata, Shingo
Ichikawa, Tomonaga
Saito, Yusuke
Taki, Tomohiko
Taniwaki, Masafumi
Morishita, Kazuhiro
CANCER SCIENCE, 2018, 109 : 198 - 198
[38] BCL11b Gene Is Targeted by Structural and Numerical Chromosomal Aberrations in Mature T-Cell Lymphoma
Haralambieva, E.
Leich, E.
Marques-Maggio, E.
Bachmann, E.
Zettl, A.
Rosenwald, A.
Mueller-Hermelink, H. K.
Pulford, K.
LABORATORY INVESTIGATION, 2010, 90 : 300A - 301A
[39] A far downstream enhancer for murine Bcl11b controls its T-cell specific expression
Li, Long
Zhang, Jingli A.
Dose, Marei
Kueh, Hao Yuan
Mosadeghi, Ruzbeh
Gounari, Fotini
Rothenberg, Ellen V.
BLOOD, 2013, 122 (06) : 902 - 911
[40] T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival
Chen, Cunte
Huang, Ling
Liu, Sichu
Jiang, Xinmiao
Chen, Feili
Wei, Xiaojuan
Guo, Hanguo
Zeng, Xiangbo
Zeng, Chengwu
Przybylski, Grzegorz K.
Li, Wenyu
Li, Yangqiu
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2024, 20 (01) : 81 - 86

← 1 2 3 4 5 →